Sunshine Biopharma (SBFM) Stock Chart & Stock Price History $1.47 -0.02 (-1.60%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sunshine Biopharma Stock Price Performance The Sunshine Biopharma (SBFM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 50.00%, with a year-to-date return of -51.33%. In the past month, the stock has decreased 6.41%, reflecting recent market activity. As of the latest close, Sunshine Biopharma traded at $1.49 with a market cap of $6.79 million and volume of 26,682 shares. Receive SBFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.67%1 Month Performance-6.41%3 Month Performance-2.67%Year-To-Date Performance-51.33%1 Year Performance-50.00% SBFM Stock Chart for Monday, August, 18, 2025 SBFM Chart by TradingView Sunshine Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.51$1.49-1.33%$1.52$1.4626,682 shs$6.79 million08/14/2025$1.50$1.51+0.67%$1.51$1.4266,466 shs$6.88 million08/13/2025$1.42$1.50+5.63%$1.52$1.4158,925 shs$6.84 million08/12/2025$1.43$1.42-0.70%$1.44$1.3942,663 shs$6.48 million08/11/2025$1.40$1.43+2.14%$1.43$1.3636,854 shs$6.52 million08/08/2025$1.40$1.40$1.41$1.3633,434 shs$6.38 million08/07/2025$1.40$1.40$1.44$1.3644,725 shs$6.38 million08/06/2025$1.43$1.40-2.10%$1.43$1.3947,338 shs$6.38 million08/05/2025$1.46$1.43-2.05%$1.50$1.4236,826 shs$6.52 million08/04/2025$1.41$1.46+3.55%$1.49$1.4159,605 shs$6.66 million Get the Latest News and Ratings for SBFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$1.44$1.41-2.08%$1.44$1.3562,221 shs$6.43 million07/31/2025$1.47$1.44-2.04%$1.52$1.4348,092 shs$6.57 million07/30/2025$1.51$1.47-2.65%$1.56$1.4341,744 shs$6.70 million07/29/2025$1.52$1.51-0.66%$1.56$1.4854,713 shs$6.89 million07/28/2025$1.56$1.52-2.56%$1.57$1.5154,784 shs$6.93 million07/25/2025$1.55$1.56+0.65%$1.57$1.5070,701 shs$7.11 million07/24/2025$1.58$1.55-1.90%$1.59$1.5464,576 shs$7.07 million07/23/2025$1.59$1.58-0.63%$1.60$1.51120,891 shs$7.20 million07/22/2025$1.56$1.59+1.92%$1.60$1.5446,791 shs$7.25 million07/21/2025$1.56$1.56$1.61$1.5459,685 shs$7.11 million07/18/2025$1.60$1.56-2.50%$1.60$1.5472,307 shs$7.11 million07/17/2025$1.52$1.60+5.26%$1.60$1.5398,948 shs$7.29 million Related Companies DYAI Stock Chart NNVC Stock Chart TENX Stock Chart LSTA Stock Chart JATT Stock Chart MIRA Stock Chart NAII Stock Chart FBLG Stock Chart CVKD Stock Chart CING Stock Chart Receive SBFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SBFM) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access